Skip to main content
. 2017 Feb 1;82:50–57. doi: 10.12659/PJR.899239

Figure 3.

Figure 3

(A) ROC curves for DCECT, DCEMRI and HB phase-enhanced MRI, in the total number of lesions (n. 125). AUC value is 0.984 for DCEMRI+HB phase vs. 0.934 for DCEMRI (<0.68) and 0.852 for DCECT (p<0.001). (B) ROC curves for DCECT, DCEMRI and HB phase-enhanced MRI, for lesions >20 mm (n. 40). No significant differences are observed among the three imaging modalities with AUC values of 0.984 for DCEMRI+HB phase, 0.999 for DCEMRI and 0.913 for DCECT. (C) ROC curves for DCECT, DCEMRI and HB phase-enhanced MRI, for lesions <20 mm (n. 85). AUC value is 0.982 for DCEMRI+HB phase vs. 0.910 for DCEMRI (p<0.01) and 0.828 for DCECT (p<0.001).